Cargando…

Correction: TBProfiler for automated calling of the association with drug resistance of variants in Mycobacterium tuberculosis

Detalles Bibliográficos
Autores principales:	Verboven, Lennert, Phelan, Jody, Heupink, Tim H., Van Rie, Annelies
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581449/ https://www.ncbi.nlm.nih.gov/pubmed/37847720 http://dx.doi.org/10.1371/journal.pone.0293254

Ejemplares similares

TBProfiler for automated calling of the association with drug resistance of variants in Mycobacterium tuberculosis
por: Verboven, Lennert, et al.
Publicado: (2022)

Comprehensive and accurate genetic variant identification from contaminated and low-coverage Mycobacterium tuberculosis whole genome sequencing data
por: Heupink, Tim H., et al.
Publicado: (2021)

The MAGMA pipeline for comprehensive genomic analyses of clinical Mycobacterium tuberculosis samples
por: Heupink, Tim H., et al.
Publicado: (2023)

A large scale evaluation of TBProfiler and Mykrobe for antibiotic resistance prediction in Mycobacterium tuberculosis
por: Mahé, Pierre, et al.
Publicado: (2019)

Detection of minor variants in Mycobacterium tuberculosis whole genome sequencing data
por: Goossens, Sander N, et al.
Publicado: (2021)

A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis
por: Verboven, Lennert, et al.
Publicado: (2023)

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial
por: Van Rie, Annelies, et al.
Publicado: (2022)

Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosis
por: Whitfield, Michael G., et al.
Publicado: (2022)

Author Correction: Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Khan, Anwar Sheed, et al.
Publicado: (2021)

Mixed infections in genotypic drug-resistant Mycobacterium tuberculosis
por: Wang, Linfeng, et al.
Publicado: (2023)

Capacity building for whole genome sequencing of Mycobacterium tuberculosis and bioinformatics in high TB burden countries
por: Rivière, Emmanuel, et al.
Publicado: (2020)

A treatment recommender clinical decision support system for personalized medicine: method development and proof-of-concept for drug resistant tuberculosis
por: Verboven, Lennert, et al.
Publicado: (2022)

Correction to: Detection of Mycobacterium tuberculosis in pediatric stool samples using TruTip technology
por: Mesman, Annelies W., et al.
Publicado: (2019)

Understanding molecular consequences of putative drug resistant mutations in Mycobacterium tuberculosis
por: Portelli, Stephanie, et al.
Publicado: (2018)

Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis
por: Napier, Gary, et al.
Publicado: (2023)

Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa
por: Oostvogels, Selien, et al.
Publicado: (2022)

Correction: Population Structure among Mycobacterium tuberculosis Isolates from Pulmonary Tuberculosis Patients in Colombia
Publicado: (2014)

Correction: Prokaryotic Ubiquitin-Like Protein (Pup) Proteome of Mycobacterium tuberculosis
por: Festa, Richard A., et al.
Publicado: (2010)

Correction: Global Assessment of Genomic Regions Required for Growth in Mycobacterium tuberculosis
por: Zhang, Yanjia J., et al.
Publicado: (2013)

Correction: Identification of Rv3852 as an Agrimophol-Binding Protein in Mycobacterium tuberculosis
Publicado: (2015)

Correction to “Meningitis caused by Mycobacterium tuberculosis in a recent immigrant to Canada”
Publicado: (2022)

Publisher Correction: Genomic analysis of the emergence of drug-resistant strains of Mycobacterium tuberculosis in the Middle East
por: Alyamani, Essam J., et al.
Publicado: (2019)

Author Correction: A novel recombinant DNA vaccine encoding Mycobacterium tuberculosis ESAT-6 and FL protects against Mycobacterium tuberculosis challenge in mice
por: Jiang, Qingtao, et al.
Publicado: (2022)

The devil is in the diversity: Exploring within-person evolution of Mycobacterium tuberculosis
por: Van Rie, Annelies, et al.
Publicado: (2020)

Correction: Whole Cell Screen for Inhibitors of pH Homeostasis in Mycobacterium tuberculosis
por: Darby, Crystal M., et al.
Publicado: (2013)

Correction: Two-Step Synthesis and Hydrolysis of Cyclic di-AMP in Mycobacterium tuberculosis
Publicado: (2014)

Correction: Crystal Structures of the Kinase Domain of the Sulfate-Activating Complex in Mycobacterium tuberculosis
Publicado: (2015)

Correction: In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Correction: Alternate splicing of transcripts shape macrophage response to Mycobacterium tuberculosis infection
por: Kalam, Haroon, et al.
Publicado: (2018)

Correction to: DivBrowse—interactive visualization and exploratory data analysis of variant call matrices
Publicado: (2023)

A modified decision tree approach to improve the prediction and mutation discovery for drug resistance in Mycobacterium tuberculosis
por: Deelder, Wouter, et al.
Publicado: (2022)

Portable sequencing of Mycobacterium tuberculosis for clinical and epidemiological applications
por: Gómez-González, Paula J, et al.
Publicado: (2022)

Correction: Sepsis, a call for inclusion in the work plan of the European Center for Disease Prevention and Control
por: Giamarellos-Bourboulis, Evangelos J., et al.
Publicado: (2023)

Author Correction: Establishing Virulence Associated Polyphosphate Kinase 2 as a drug target for Mycobacterium tuberculosis
por: Singh, Mamta, et al.
Publicado: (2020)

Author Correction: Establishing Virulence Associated Polyphosphate Kinase 2 as a drug target for Mycobacterium tuberculosis
por: Singh, Mamta, et al.
Publicado: (2021)

Correction: LprG-Mediated Surface Expression of Lipoarabinomannan Is Essential for Virulence of Mycobacterium tuberculosis
Publicado: (2014)

Correction: Genetic Diversity and Transmission Characteristics of Beijing Family Strains of Mycobacterium tuberculosis in Peru
por: Iwamoto, Tomotada, et al.
Publicado: (2013)

Correction: The ESX-3 Secretion System Is Necessary for Iron and Zinc Homeostasis in Mycobacterium tuberculosis
por: Serafini, Agnese, et al.
Publicado: (2014)

Correction: LprG-Mediated Surface Expression of Lipoarabinomannan Is Essential for Virulence of Mycobacterium tuberculosis
por: Gaur, Rajiv L., et al.
Publicado: (2015)

Correction to: COVID-19 and people who use drugs: a call for action
por: Jozaghi, Ehsan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mtd7km8ollb57npt07p5a4bu8d